Nordea Investment Management Ab rotates from mega-cap AI to durable cash-flow moats

The biggest incremental dollar adds show Nordea leaning into real‑economy infrastructure and select platform franchises rather than blindly piling into the next AI leg. Amazon, Apple and Micron get more capital, but the bolder moves are in rails, hospitals, animal health, power and even sleepy telecom.

Key conviction builds:

• AMZN (Amazon): A top conviction consumer platform, with the stake up 9.7% (+$276.4M). Nordea is clearly betting that cloud, logistics and retail scale will keep compounding even if AI multiples wobble.
• AAPL (Apple): Shares are up 3.6% (+$197.0M). Rather than trimming after a strong run, they lean further into Apple’s ecosystem cash machine as a core anchor of the tech complex.
• VZ (Verizon): A 48.4% increase (+$173.1M) is a loud signal. Nordea is embracing telecom as an income‑like, infrastructure play with modest upside, trading near their cost basis and offering ballast against tech volatility.
• HCA (HCA Healthcare): Shares jump 33.5% (+$168.2M). This is a high‑conviction bet on hospital operations benefiting from normalized volumes, pricing power and demographic tailwinds instead of binary drug pipelines.
• NEE (NextEra Energy): Up 29.5% (+$155.4M). Despite being labeled tech in the feed, this is effectively a renewables‑heavy utility; Nordea is paying up for long‑duration, regulated plus growth cash flows.
• WAB (Wabtec): A 15.9% add (+$118.2M) into rail equipment and services shows a view that North American and global freight upgrades will be a durable, under‑the‑radar compounder.
• EXC (Exelon): A 27.8% increase (+$108.4M) furthers the utility theme — more exposure to transmission, grid and baseload power as quasi‑infrastructure.
• ZTS (Zoetis): Shares up 18.9% (+$108.1M) despite the position sitting 44.2% below their average cost. That’s a rare move: they’re averaging down into animal health as a secular growth story, not bailing on near‑term drawdown.

Taken together, these adds say Nordea is rotating into operating leverage and essential services where volumes and pricing, not hype, drive the P&L — while keeping a tight core in the dominant tech platforms.

Nordea’s biggest trims read like disciplined profit‑taking in positions where the thesis worked almost too well. They’re not exiting AI or health care; they’re normalizing exposure in names that have already delivered enormous gains versus cost.

On the tech side, Lam Research is the clearest signal. A 16.4% cut (‑$249.3M) comes after a 422.2% gain versus their average buy price, and Applied Materials is down 8.9% (‑$65.6M) after a 254.7% gain. Microsoft is trimmed 4.7% (‑$244.9M), while Alphabet’s GOOGL line is shaved 3.2% (‑$82.3M) even as they add slightly to the GOOG class — fine‑tuning position sizing and share‑class mix rather than a view change on the businesses.

The other clear funding bucket is mature, lower‑growth pharma and chemicals. Merck is down 19.3% (‑$244.5M), Johnson & Johnson 14.2% (‑$188.9M), Linde 11.1% (‑$117.5M), McKesson 7.8% (‑$71.3M), Amgen 3.2% (‑$28.5M) and AbbVie is actually increased, not cut. Nordea is pruning the most fully valued, slower‑growth health‑care exposures to pay for higher‑growth or more operationally leveraged names like HCA and Zoetis.

Payments and consumer staples get modest trims rather than full rotations. Visa is down 10.2% (‑$83.6M) and the Mastercard stake is 4.5% lighter (‑$53.1M), while real‑estate‑classified eBay shrinks 5.2% (‑$32.6M). These moves look like sizing discipline in long‑term winners, not a macro call against the consumer or payments rails.

Sector data shows Nordea isn’t abandoning tech leadership — it’s sanding down the edges. Technology slips only marginally from 52.09% to 51.71% of the disclosed book, even as they take sizeable profits in Lam Research, Microsoft and Applied Materials. Adds to Apple, Amazon, Micron, Fortinet and NextEra (classified as tech here but economically a utility) keep the AI and digital‑infrastructure story intact.

Health care nudges down from 13.65% to 13.24% as they rotate within the sector, out of Merck, Johnson & Johnson, McKesson and into HCA and Zoetis. That’s a quality‑of‑growth upgrade: less exposure to reimbursement‑capped big pharma, more to operators and specialty niches with volume and pricing power.

Consumer discretionary edges higher from 9.47% to 9.88% on the back of Amazon, Netflix, Snap‑on and Ecolab, signaling confidence in resilient, higher‑income consumption rather than early‑cycle cyclicals. Finance ticks up from 5.98% to 6.06% as they quietly add to JPMorgan, Citigroup, American Express, Hartford and Wells Fargo, suggesting they see more upside in rate‑sensitive franchises than risk.

Below the headline sectors, the story is infrastructure and staples. Industrials rise from 2.92% to 3.12% via Trane and Wabtec; utilities climb from 2.75% to 2.84% via Exelon despite a trim in Republic Services; consumer staples move from 1.28% to 1.48% with sizable adds in PepsiCo and Kroger. Real estate slips from 5.05% to 4.78% as Visa, Mastercard and eBay are trimmed while Equinix is topped up, focusing the sleeve on digital infrastructure over consumer internet rerating.

If the last few quarters were about owning the AI narrative, this one is about surviving its volatility. Nordea is not calling a top in semis or megacap software; instead, they are systematically taking money off the most explosive winners and reallocating into platforms, infrastructure and services that should earn through a bumpier equity and rates regime.

The adds to Verizon, Exelon, NextEra and Wabtec say they want more exposure to regulated assets, grid and rail capacity — the physical backbone that both AI data centers and the broader economy require. HCA and bank adds suggest a view that the cycle is not rolling over; they are comfortable owning credit‑sensitive and volume‑sensitive operators, but in market leaders with proven pricing and cost control.

On the risk side, they are willingly keeping over half the book in tech, with meaningful incremental dollars still going into Amazon, Apple, Micron and Fortinet. The implicit bet is that AI and cloud remain the growth engine, but returns will be enhanced — and drawdowns cushioned — by a growing ring of boring, cash‑rich infrastructure names around the core.

Going forward, watch two axes: whether they continue averaging down in underperformers like Zoetis and whether they further rotate from AI equipment (Lam, Applied Materials) into utilities, rails and data‑center real estate. If those trends persist, Nordea will have quietly morphed its AI winner’s portfolio into a more classic, cash‑flow‑centric compounder book without ever letting go of the secular growth story.